Related Experiment Videos
Lost in menopausal transition: the timing of atherosclerosis prevention in women
1Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. japi@ikem.cz.
Abstract:
Advanced atherosclerotic changes can often resist even to very aggressive treatment. Although basic mechanisms of its origin and development are known, some important steps in this process are still waiting for more detailed explanation. Therefore, in addition to already proved aggressive lowering of LDL cholesterol, appropriate timing of atherosclerosis treatment is of the essence. Revealing different stages of atherosclerotic process, less or more sensitive to treatment is of primary importance; however, its detection is complicated by several facts including not exactly identifiable periods of quiescence and progression of atherosclerotic process. One of populations, study of which could add valuable information regarding this problem, are women in menopausal transition. Previously unsuccessful therapy with hormone replacement therapy is restudied with focus on the time of/after menopause. Now, it is supposed to be favorable in women soon, approximately less than 8 years, after menopause. In addition, the same principle - optimal timing of the intervention of traditional cardiovascular risk factors, especially lipids, could be also of importance. Therefore, menopausal transition could be optimal period for the intervention in women at risk. However, this approach is to be proved by evidence from controlled prospective studies focused on lifestyle and/or pharmacological intervention.
Insights
Optimal timing for treating atherosclerosis is crucial, especially for women in menopausal transition. Early intervention targeting cardiovascular risk factors during this period may improve outcomes, but requires further research.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Gerontology
Background:
- Advanced atherosclerosis often proves resistant to aggressive treatments.
- The precise mechanisms and optimal intervention timing for atherosclerosis remain incompletely understood.
- Menopausal transition presents a unique window for studying atherosclerosis progression and treatment efficacy.
Purpose of the Study:
- To investigate the significance of intervention timing in atherosclerosis treatment.
- To explore the potential of menopausal transition as a critical period for cardiovascular risk factor management in women.
- To re-evaluate hormone replacement therapy (HRT) efficacy based on menopausal timing.
Main Methods:
- Review of current understanding of atherosclerosis development and treatment resistance.
- Analysis of the role of menopausal transition in cardiovascular health.
- Consideration of evidence regarding hormone replacement therapy timing post-menopause.
Main Results:
- Aggressive lipid-lowering alone may not suffice for advanced atherosclerosis.
- The timing of intervention for cardiovascular risk factors, particularly lipids, is critical.
- Hormone replacement therapy may be more effective when initiated within 8 years after menopause.
Conclusions:
- Menopausal transition may represent an optimal period for intervening in cardiovascular risk factors for at-risk women.
- Further evidence from controlled prospective studies is needed to validate lifestyle and pharmacological interventions during this period.
- Understanding the dynamic stages of atherosclerosis is key to developing effective, timely treatments.